NIH Avastin Study Results Could Change Prescribing for Cervical Cancer

Drug Industry Daily
A A
Adding Genentech’s Avastin to chemotherapy extends the life of cervical cancer patients compared with chemotherapy alone, an NIH-sponsored study finds.

To View This Article:

Login

Subscribe To Drug Industry Daily